Aeon Biopharma Inc (AEON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 166 | 497 | 664 | 989 | 1,442 |
| TOTAL | $519 | $835 | $1,028 | $1,380 | $2,138 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 276,129 | 276,114 | 276,175 | 276,235 | 276,008 |
| TOTAL | $276,129 | $276,114 | $276,175 | $276,235 | $276,008 |
| Total Assets | $276,647 | $276,950 | $277,203 | $277,615 | $278,147 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 742 | 635 | 74 | 107 | 4 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 314 |
| Other current liabilities | N/A | N/A | N/A | N/A | 100 |
| TOTAL | $792 | $835 | $224 | $206 | $468 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 290,012 | 293,045 | 294,157 | 300,246 | 296,522 |
| TOTAL | $290,012 | $293,045 | $294,157 | $300,246 | $296,522 |
| Total Liabilities | $290,804 | $293,879 | $294,381 | $300,452 | $296,990 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 480 | 480 | 480 | 551 | 551 |
| Common Shares | 1 | 1 | 1 | 0 | 1 |
| Retained earnings | -14,189 | -16,963 | -17,210 | -22,869 | -18,844 |
| Other shareholders' equity | 0 | 0 | 0 | 1 | 0 |
| TOTAL | $-14,157 | $-16,930 | $-17,178 | $-22,837 | $-18,844 |
| Total Liabilities And Equity | $276,647 | $276,950 | $277,203 | $277,615 | $278,147 |